1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. IRHYTHM TECHNOLOGIES INC
iRhythm Technologies Inc
XNAS: IRTC
104.99-2.21(-2.06%)
450.3K
XNAS Volume

XNAS 07 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

iRhythm Tech Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for iRhythm Tech Inc share price target, revenues, EPS, net income and more

iRhythm Tech Inc quarterly results: revenue, profit, and P&L – 13 quarter history

  • POSITIVE

    Quarterly Revenue iRhythm Tech Inc Jun-2026 Quarterly Revenue is $224 Million which is growth of 20.1% YoY.

  • POSITIVE

    Quarterly Net Profit iRhythm Tech Inc Jun-2026 Quarterly Net Profit is $-0 Million which is growth of 97.3% YoY.

iRhythm Technologies Inc, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
224.2199.4208.9192.9186.7158.7164.3147.5148.1131.9132.5124.6124.1
Cost Of Rev.
615860.855.853.849.549.346.144.644.445.142.137.9
Gross Profit
163.2141.4148.1137.1132.9109.2115.1101.5103.587.587.482.586.2
⌄
151.8157.5143.8145.6149.1141.8119.2151.1126.5125.7115.5110.1105.1
Operating Profit
11.4-16.24.3-8.4-16.2-32.6-4.1-49.7-23-38.1-28.1-27.6-18.9
1.51.622.721.72.43.13.10.10.70.70.6
Profit Before Tax
-0.4-13.46-5.2-14.4-30-1.2-46-19.9-45.6-38.4-26.9-18.3
Tax
0.50.50-0.20.70.20.20.200.30.20.2
⌄
-0.4-13.95.6-5.2-14.2-30.7-1.3-46.2-20.1-45.7-38.7-27.1-18.5
Diluted NI Avail to Com Stockholders Ann.
-0.4-13.95.6-5.2-14.2-30.7-1.3-46.2-20.1-45.7-38.7-27.1-18.5
Basic EPS
-0-0.40.2-0.2-0.4-1-0-1.5-0.7-1.5-1.3-0.9-0.6
Diluted EPS After ExtraOrdinary
0.4-0.40.2-0.2-0.4-1-0-1.5-0.7-1.3-1-0.9-0.6
Number Of Shares End
32.932.532.332.23231.631.331.331.13130.730.630.5
Net Income Continuing Discontinued Operations
-0.4-13.95.6-5.2-14.2-30.7-1.3-46.2-20.1-45.7-38.7-27.1-18.5
Normalized Income
13.6-13.97.4-5.2-11.8-30.7-1.3-45.7-20.1-39.7-30-27.1-18.5
Interest Income
4.84.95.35.95.34.95.76.56.431.71.61.4
Interest
2.52.55.62.52.52.53.33.33.32.90.90.90.8
Net Interest Income
1.51.622.721.72.43.13.10.10.70.70.6
EBIT
2.1-1111.7-2.7-11.9-27.62.1-42.7-16.6-42.8-37.5-26-17.4
EBITDA
8.9-4.418.44-5.4-218.7-36.3-10.2-36.4-31-20.4-12.3
Reconciled Cost Of Rev.
615860.855.853.849.549.346.144.644.445.142.137.9
Reconciled Depr.
6.86.56.76.66.56.66.66.46.46.46.55.65.2
Profit From Continuing Operations
-0.4-13.95.6-5.2-14.2-30.7-1.3-46.2-20.1-45.7-38.7-27.1-18.5
Normalized EBITDA
22.8-4.420.44-2.9-218.7-35.6-10.2-28.8-20-20.4-12.3
*All financials are in USD Million and price data in USD

iRhythm Tech Inc competitor comparison and performance snapshot within industry

iRhythm Tech Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

  • POSITIVE

    Annual Revenue iRhythm Tech Inc Dec-2025 Annual Revenue is $747 Million which is growth of 26.2% YoY.

  • POSITIVE

    Annual Net Profit iRhythm Tech Inc Dec-2025 Annual Net Profit is $-45 Million which is growth of 60.7% YoY.

iRhythm Technologies Inc, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
22.1%
23%
 747.1591.8492.7410.9322.8265.2214.6147.398.564.136.1
Cost Of Rev. Ann.
19.4%
25.6%
235.6219.9184.3160.9129.3109.370.352.538.627.720.914.7
Gross Profit Ann.
23.3%
22%
589.7527.3407.5331.8281.6213.6194.9162.1108.770.843.221.4
Operating Exp. Ann.
16.3%
19.4%
598.7580.2522.4445.9368.8313.5238.6216.8152.398.158.843.1
Operating Profit Ann.
-
-
-8.9-53-114.9-114.1-87.2-99.9-43.7-54.8-43.6-27.3-15.6-21.6
-
-
7.88.49.12.5-4.1-1.2-1.5-1.6-3.1-3.4-3.3-1.1
Other Exp. Ann.
-
-9%
 1-7-11.1-24.60.11.61.9-1.51.2-2.1-0.1
PBT Ann.
-
-
-13-43.6-112.7-122.7-115.9-101-43.6-54.5-48.2-29.4-20.9-22.8
Tax Ann.
49.4%
38%
110.60.80.30.40.20.10---
⌄
-
-
-13.9-44.6-113.3-123.4-116.2-101.4-43.8-54.6-48.3-29.4-20.9-22.7
Diluted NI Avail to Com Stockholders Ann.
-
-
-13.9-44.6-113.3-123.4-116.2-101.4-43.8-54.6-48.3-29.4-20.9-22.7
EPS Ann.
-
-
 -1.4-3.6-4-3.9-3.5-1.6-2.2-2-1.3-4-1.6
Diluted EPS Ann.
-
-
 -1.4-3.6-4-3.9-3.5-1.6-2.2-2-1.3-4-1.6
Number Of Shares End
2.3%
2.2%
 32.331.330.730.229.428.926.624.323.222.114.8
Total Exp. Ann.
17.1%
21%
 800.1706.7606.8498.1422.8308.8269.3190.9125.879.757.8
Net Income Continuing Discontinued Operations Ann.
-
-
-13.9-44.6-113.3-123.4-116.2-101.4-43.8-54.6-48.3-29.4-20.9-22.8
Normalized Income Ann.
-
-
1.8-41-106.8-114.7-95.1-101.4-43.8-54.6-46.1-29.4-20.9-22.8
Interest Income Ann.
-
-
20.921.521.96.2--------
Interest Ann.
47.7%
54.5%
13.213.212.83.74.11.21.51.63.13.43.31.1
EBITDA Ann.
-
-
26.8-4-74.1-96.9-92.1-90-35.2-49.4-42.9-24.4-17.1-21.3
Reconciled Cost Of Rev. Ann.
19.4%
25.6%
235.6219.9184.3160.9129.3109.370.352.538.627.720.914.7
Reconciled Depr. Ann.
10.6%
30.9%
26.626.525.822.119.69.86.93.42.31.60.60.5
Profit From Continuing Operations Ann.
-
-
-13.9-44.6-113.3-123.4-116.2-101.4-43.8-54.6-48.3-29.4-20.9-22.8
Normalized EBITDA Ann.
-
-
42.80.5-65.9-85.8-65.5-90-35.2-49.4-39.8-24.4-17.1-21.3
*All financials are in USD Million and price data in USD
Total Rev. Ann.
1Y CHG
26.2%
2Y CAGR
23.1%
3Y CAGR
22.1%
5Y CAGR
23%
7Y CAGR
26.1%
10Y CAGR
35.4%
Total Revenue Annual growth is higher than historical averages.
Operating Exp. Ann.
1Y CHG
11.1%
2Y CAGR
14.1%
3Y CAGR
16.3%
5Y CAGR
19.4%
7Y CAGR
21.1%
10Y CAGR
29.7%
Operating Expenses Annual Cr growth is lower than historical averages.

iRhythm Tech Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

  • POSITIVE

    Total Shareholders Fund iRhythm Tech Inc Dec-2025 Total Shareholders Fund is $153 Million which is growth of 68.0% YoY.

  • POSITIVE

    Total Assets iRhythm Tech Inc Dec-2025 Total Assets is $1,020 Million which is growth of 9.5% YoY.

iRhythm Technologies Inc, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
31.5%
14.8%
1,020931.5433.1448.2463511.7306.2119.7133.1138.237.9
⌄
60.9%
38.5%
867.3840.5223.1208.4183.5170.1170.865.353.645.6139.5
⌄
-13.9%
-14.9%
152.890.9210.1239.8279.5341.6135.454.479.692.6-101.6
Total Capitalization Ann.
42.9%
17.2%
802.3737.4245.1274.8289.2363168.489.3112124.8-71.1
Tangible Assets Ann.
-14%
-14.9%
151.990.1209.2239278.7340.8134.653.678.791.7-102.5
Working Capital Ann.
40.2%
12%
550.9534.9123.4199.7217.7312.2120.776.398.7105.424.1
Invested Capital Ann.
42.9%
16.5%
802.3737.4245.1274.8300.9374.6170.389.3113.5124.8-71.1
Tangible Book Value Ann.
-14%
-14.9%
151.990.1209.2239278.7340.8134.653.678.791.7-102.5
Borrowings Ann.
77.4%
42.9%
731.2736.9129.8131117.7122.5128.634.93432.230.6
Net Debt Ann.
-
-
413.5226.9----14.514.925.3-5.3
Share Issued Ann.
2.5%
2.3%
32.531.63130.229.52926.724.423.422.120.2
Number Of Shares End
2.3%
2.2%
32.331.330.730.229.428.926.624.323.222.114.8
*All financials are in USD Million and price data in USD
Total Assets Ann.
1Y CHG
9.5%
2Y CAGR
53.5%
3Y CAGR
31.5%
5Y CAGR
14.8%
7Y CAGR
35.8%
10Y CAGR
39%
Total Assets Annual growth is lower than historical averages.
Total Current Liabilities Ann.
1Y CHG
37%
2Y CAGR
18.9%
3Y CAGR
19.5%
5Y CAGR
18.2%
7Y CAGR
26%
10Y CAGR
33%
Total Current Liabilities Annual Cr growth is higher than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
68.1%
2Y CAGR
-14.7%
3Y CAGR
-13.9%
5Y CAGR
-14.9%
7Y CAGR
15.9%
Total ShareHolders Funds Annual growth is higher than historical averages.

iRhythm Tech Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

  • POSITIVE

    Book Value Per Share iRhythm Tech Inc Book Value Per Share is $6 which is growth of 74.9% YoY.

  • NEUTRAL

    ROE iRhythm Tech Inc ROE is 0% which is growth of 0% YoY.

iRhythm Technologies Inc, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
RoA Ann. %
-
-
--16.60%-28.00%-25.50%-20.80%-10.72%-25.62%-38.19%-21.69%-23.75%-80.48%
ROE Ann. %
-
-
--75.27%-54.86%-44.73%-32.64%-18.38%-57.49%-72.07%-34.19%--
ROIC %
-
-
--0.4-11.4-5.3-7.9-2-6.3-15.3-8.9--
OPM Ann. %
-
-
-7.09%-19.41%-23.16%-21.21%-30.96%-16.47%-25.52%-29.61%-27.68%-24.32%-59.85%
Inventory Turnover Ratio Ann.
-
-
-13.211.110.2141517.220.61816.515
Asset Turnover Ann. %
-
-
-0.91.10.90.70.711.20.70.71.3
Working Capital Turnover Ann.
-12.6%
9.2%
1.41.142.11.50.91.81.910.61.5
Quick Ratio Ann.
-
-
-5.61.833.35.63.23.35.58.73.5
Current Ratio Ann.
-
-
-5.82.23.23.55.83.33.55.793.7
Interest Coverage Ratio Ann.
-
-
--7.8-32.6-27-85.4-27.7-32.2-14.5-7.7-5.4-20.5
LT Debt To Equity Ann.
-
-
-7.90.60.50.30.30.90.60.40.4-
*All financials are in USD Million and price data in USD

iRhythm Tech Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

  • POSITIVE

    Cash From Operating Activity iRhythm Tech Inc Dec-2025 Cash From Operating Activity is $81 Million which is growth of 2285.3% YoY.

  • NEGATIVE

    Net Cash Flow iRhythm Tech Inc Dec-2025 Net Cash Flow is $-184 Million which is growth of -146.9% YoY.

iRhythm Technologies Inc, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-
-
80.93.4-50.1-23-37.8-13.8-21.9-29.1-14.9-16.7-18
-
-
-277.1-123-1.2-52.4105.3-132.4-89.334.1-34.6-68.2-1.8
-22.1%
-43.3%
12.6511.48.826.7-28.6214.3111.66.36.5111.336.4
Cash Plus Cash Eqv. End Of Year Ann.
45.8%
22.5%
244.442836.278.8127.688.620.5208.751.625.2
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-
-183.6391.8-42.5-48.738.968.20.411.4-4326.416.6
Cash Plus Cash Eqv. Begin Of Year Ann.
49.7%
83.6%
42836.278.8127.688.620.5208.751.625.28.6
Income Tax Paid Supplemental Data Ann.
-
-
0.90.91.1--------
Interest Paid Supplemental Data Ann.
4.8%
20.4%
3.86.433.31.21.51.66.11.61.60.3
Capex Ann.
-
-
-46.3-48.9-40.4-29.8-28.1-13.6-20.5-5.2-3.6-2.8-1.8
Issuance Of Capital Stock Ann.
-
-
---206116.9-114.412.1
Issuance Of Debt Ann.
-
-
736.335--35-29
Repayment Of Debt Ann.
-
-
-116.4-21.4-11.7-1.9-31.5--4.9
Repurchase Of Capital Stock Ann.
-
-
-25---------
Free Cash Flow Ann.
-
-
34.5-45.6-90.5-52.8-65.8-27.3-42.3-34.3-18.5-19.4-19.8
*All financials are in USD Million and price data in USD
Cash from Operating Act. Ann.
1Y CHG
2279.4%
Cash from Operating Activity Annual growth is higher than historical averages.
Cash from Financing Act. Ann.
1Y CHG
-97.5%
2Y CAGR
19.7%
3Y CAGR
-22.1%
5Y CAGR
-43.3%
7Y CAGR
10.4%
10Y CAGR
-10.1%
Cash from Financing Annual Activity is falling faster than historical averages.